Albert Feghaly
Overview
Explore the profile of Albert Feghaly including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
121
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Quenneville J, Feghaly A, Tual M, Thomas K, Major F, Gagnon E
Cancer Gene Ther
. 2024 Jul;
31(8):1237-1250.
PMID: 38977895
The majority of cancer deaths are caused by solid tumors, where the four most prevalent cancers (breast, lung, colorectal and prostate) account for more than 60% of all cases (1)....
2.
Bordeleau M, Audemard E, Metois A, Theret L, Lisi V, Farah A, et al.
Cell Rep
. 2024 Jun;
43(6):114260.
PMID: 38838225
Immunotherapy remains underexploited in acute myeloid leukemia (AML) compared to other hematological malignancies. Currently, gemtuzumab ozogamicin is the only therapeutic antibody approved for this disease. Here, to identify potential targets...
3.
Dumont-Lagace M, Feghaly A, Meunier M, Finney M, Vant Hof W, Frenet E, et al.
Transplant Cell Ther
. 2023 Sep;
30(8):822.
PMID: 37726096
No abstract available.
4.
Thura D, Cabana J, Feghaly A, Cisek P
PLoS Biol
. 2022 Dec;
20(12):e3001861.
PMID: 36520685
Recent theoretical models suggest that deciding about actions and executing them are not implemented by completely distinct neural mechanisms but are instead two modes of an integrated dynamical system. Here,...
5.
Lisi V, Blanchard E, Vladovsky M, Audemard E, Feghaly A, Lemieux S, et al.
Blood Adv
. 2022 Jul;
6(17):5160-5164.
PMID: 35849707
No abstract available.
6.
Dumont-Lagace M, Feghaly A, Meunier M, Finney M, Vant Hof W, Frenet E, et al.
Transplant Cell Ther
. 2022 Mar;
28(7):410.e1-410.e5.
PMID: 35311667
Cord blood (CB) stem cell transplantation offers a greater tolerance to HLA mismatches compared to adult-derived stem cell transplants (i.e., bone marrow or peripheral blood stem cells). Indeed, 4/6 or...
7.
Daouda T, Dumont-Lagace M, Feghaly A, Benslimane Y, Panes R, Courcelles M, et al.
PLoS Comput Biol
. 2021 Oct;
17(10):e1009482.
PMID: 34679099
MHC-I associated peptides (MAPs) play a central role in the elimination of virus-infected and neoplastic cells by CD8 T cells. However, accurately predicting the MAP repertoire remains difficult, because only...
8.
Ehx G, Larouche J, Durette C, Laverdure J, Hesnard L, Vincent K, et al.
Immunity
. 2021 Mar;
54(4):737-752.e10.
PMID: 33740418
Acute myeloid leukemia (AML) has not benefited from innovative immunotherapies, mainly because of the lack of actionable immune targets. Using an original proteogenomic approach, we analyzed the major histocompatibility complex...
9.
Audemard E, Gendron P, Feghaly A, Lavallee V, Hebert J, Sauvageau G, et al.
Life Sci Alliance
. 2019 Aug;
2(4).
PMID: 31427380
Mutations identified in acute myeloid leukemia patients are useful for prognosis and for selecting targeted therapies. Detection of such mutations using next-generation sequencing data requires a computationally intensive read mapping...
10.
Hardy M, Audemard E, Migneault F, Feghaly A, Brochu S, Gendron P, et al.
Sci Rep
. 2019 May;
9(1):7203.
PMID: 31076589
Endothelial cells have multifaceted interactions with the immune system, both as initiators and targets of immune responses. In vivo, apoptotic endothelial cells release two types of extracellular vesicles upon caspase-3...